ドルテグラビル/リルピビリン配合薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Dolutegravir/Rilpivirine Combination Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C1836
• 出版社/出版日：GlobalInfoResearch / 2019年8月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、ドルテグラビル/リルピビリン配合薬の世界市場について調べ、まとめました。種類別セグメントは、自己制作API、APIアウトソーシング等、用途別セグメントは、IT、電気通信、小売、ヘルスケア、その他等に区分しました。ドルテグラビル/リルピビリン配合薬の世界市場概観、企業動向、企業別ドルテグラビル/リルピビリン配合薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・ドルテグラビル/リルピビリン配合薬の市場概観
・ドルテグラビル/リルピビリン配合薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・ドルテグラビル/リルピビリン配合薬の企業別販売動向、市場シェア、市場集中度、競争動向
・ドルテグラビル/リルピビリン配合薬の世界市場規模
・ドルテグラビル/リルピビリン配合薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・ドルテグラビル/リルピビリン配合薬のアメリカ市場規模推移
・ドルテグラビル/リルピビリン配合薬のカナダ市場規模推移
・ドルテグラビル/リルピビリン配合薬のメキシコ市場規模推移
・ドルテグラビル/リルピビリン配合薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・ドルテグラビル/リルピビリン配合薬のドイツ市場規模推移
・ドルテグラビル/リルピビリン配合薬のイギリス市場規模推移
・ドルテグラビル/リルピビリン配合薬のロシア市場規模推移
・ドルテグラビル/リルピビリン配合薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・ドルテグラビル/リルピビリン配合薬の日本市場規模推移
・ドルテグラビル/リルピビリン配合薬の中国市場規模推移
・ドルテグラビル/リルピビリン配合薬の韓国市場規模推移
・ドルテグラビル/リルピビリン配合薬のインド市場規模推移
・ドルテグラビル/リルピビリン配合薬の東南アジア市場規模推移
・ドルテグラビル/リルピビリン配合薬の南米市場分析（ブラジル、アルゼンチン等）
・ドルテグラビル/リルピビリン配合薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・ドルテグラビル/リルピビリン配合薬の種類別分析/販売量、売上、市場シェア（自己制作API、APIアウトソーシング）
・ドルテグラビル/リルピビリン配合薬の用途別分析/市場規模（IT、電気通信、小売、ヘルスケア、その他）
・ドルテグラビル/リルピビリン配合薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・ドルテグラビル/リルピビリン配合薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dolutegravir/Rilpivirine Combination Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
ViiV Healthcare
JNJ

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Self-production API
Outsourcing of API

Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dolutegravir/Rilpivirine Combination Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dolutegravir/Rilpivirine Combination Drug, with price, sales, revenue and global market share of Dolutegravir/Rilpivirine Combination Drug in 2017 and 2018.
Chapter 3, the Dolutegravir/Rilpivirine Combination Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dolutegravir/Rilpivirine Combination Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dolutegravir/Rilpivirine Combination Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dolutegravir/Rilpivirine Combination Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Dolutegravir/Rilpivirine Combination Drug Introduction
1.2 Market Analysis by Type
1.2.1 Self-production API
1.2.2 Outsourcing of API
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ViiV Healthcare
2.1.1 Business Overview
2.1.2 Dolutegravir/Rilpivirine Combination Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 JNJ
2.2.1 Business Overview
2.2.2 Dolutegravir/Rilpivirine Combination Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 JNJ Dolutegravir/Rilpivirine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dolutegravir/Rilpivirine Combination Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Dolutegravir/Rilpivirine Combination Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Dolutegravir/Rilpivirine Combination Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Dolutegravir/Rilpivirine Combination Drug Market Analysis by Regions
4.1 Global Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
4.3 Europe Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
4.5 South America Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
5 North America Dolutegravir/Rilpivirine Combination Drug by Country
5.1 North America Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Country
5.1.1 North America Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
5.3 Canada Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
6 Europe Dolutegravir/Rilpivirine Combination Drug by Country
6.1 Europe Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
6.3 UK Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
6.4 France Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
6.5 Russia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
6.6 Italy Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug by Country
7.1 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Country (2014-2019)
7.2 China Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
7.3 Japan Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
7.4 Korea Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
7.5 India Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
8 South America Dolutegravir/Rilpivirine Combination Drug by Country
8.1 South America Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Country
8.1.1 South America Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug by Countries
9.1 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
10 Global Dolutegravir/Rilpivirine Combination Drug Market Segment by Type
10.1 Global Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Dolutegravir/Rilpivirine Combination Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Dolutegravir/Rilpivirine Combination Drug Revenue and Market Share by Type (2014-2019)
10.2 Self-production API Sales Growth and Price
10.2.1 Global Self-production API Sales Growth (2014-2019)
10.2.2 Global Self-production API Price (2014-2019)
10.3 Outsourcing of API Sales Growth and Price
10.3.1 Global Outsourcing of API Sales Growth (2014-2019)
10.3.2 Global Outsourcing of API Price (2014-2019)
11 Global Dolutegravir/Rilpivirine Combination Drug Market Segment by Application
11.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
12.1 Global Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Dolutegravir/Rilpivirine Combination Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
12.2.2 Europe Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
12.2.4 South America Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
12.3 Dolutegravir/Rilpivirine Combination Drug Market Forecast by Type (2019-2024)
12.3.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Dolutegravir/Rilpivirine Combination Drug Market Share Forecast by Type (2019-2024)
12.4 Dolutegravir/Rilpivirine Combination Drug Market Forecast by Application (2019-2024)
12.4.1 Global Dolutegravir/Rilpivirine Combination Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Dolutegravir/Rilpivirine Combination Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Dolutegravir/Rilpivirine Combination Drug Picture
Table Product Specifications of Dolutegravir/Rilpivirine Combination Drug
Figure Global Sales Market Share of Dolutegravir/Rilpivirine Combination Drug by Types in 2018
Table Dolutegravir/Rilpivirine Combination Drug Types for Major Manufacturers
Figure Self-production API Picture
Figure Outsourcing of API Picture
Figure Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Dolutegravir/Rilpivirine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Table ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Type and Applications
Table ViiV Healthcare Dolutegravir/Rilpivirine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table JNJ Basic Information, Manufacturing Base and Competitors
Table JNJ Dolutegravir/Rilpivirine Combination Drug Type and Applications
Table JNJ Dolutegravir/Rilpivirine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales by Manufacturer (2017-2018)
Figure Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Manufacturer in 2017
Figure Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Manufacturer in 2018
Table Global Dolutegravir/Rilpivirine Combination Drug Revenue by Manufacturer (2017-2018)
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Manufacturer in 2017
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Dolutegravir/Rilpivirine Combination Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Dolutegravir/Rilpivirine Combination Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue and Growth Rate (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales by Regions (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Regions (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Revenue by Regions (2014-2019)
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Regions (2014-2019)
Figure Global Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Regions in 2018
Figure North America Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure South America Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure North America Dolutegravir/Rilpivirine Combination Drug Revenue and Growth Rate (2014-2019)
Table North America Dolutegravir/Rilpivirine Combination Drug Sales by Countries (2014-2019)
Table North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries (2014-2019)
Figure North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries (2014-2019)
Figure North America Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries in 2018
Table North America Dolutegravir/Rilpivirine Combination Drug Revenue by Countries (2014-2019)
Table North America Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries in 2018
Figure United States Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Canada Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Mexico Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Revenue and Growth Rate (2014-2019)
Table Europe Dolutegravir/Rilpivirine Combination Drug Sales by Countries (2014-2019)
Table Europe Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries (2014-2019)
Table Europe Dolutegravir/Rilpivirine Combination Drug Revenue by Countries (2014-2019)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries in 2018
Figure Germany Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure UK Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure France Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Russia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Italy Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales by Countries (2014-2019)
Table Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries 2018
Table Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries 2018
Figure China Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Japan Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Korea Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure India Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure South America Dolutegravir/Rilpivirine Combination Drug Revenue and Growth Rate (2014-2019)
Table South America Dolutegravir/Rilpivirine Combination Drug Sales by Countries (2014-2019)
Table South America Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries (2014-2019)
Figure South America Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries in 2018
Table South America Dolutegravir/Rilpivirine Combination Drug Revenue by Countries (2014-2019)
Table South America Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure South America Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries in 2018
Figure Brazil Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Argentina Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Colombia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales by Countries (2014-2019)
Table Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir/Rilpivirine Combination Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure UAE Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Egypt Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Figure South Africa Dolutegravir/Rilpivirine Combination Drug Sales and Growth Rate (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales by Type (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales Share by Type (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Revenue by Type (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Revenue Share by Type (2014-2019)
Figure Global Self-production API Sales Growth (2014-2019)
Figure Global Self-production API Price (2014-2019)
Figure Global Outsourcing of API Sales Growth (2014-2019)
Figure Global Outsourcing of API Price (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales by Application (2014-2019)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Dolutegravir/Rilpivirine Combination Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales Forecast by Regions (2019-2024)
Table Global Dolutegravir/Rilpivirine Combination Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
Figure Europe Sales Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
Figure South America Sales Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Dolutegravir/Rilpivirine Combination Drug Market Forecast (2019-2024)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales Forecast by Type (2019-2024)
Table Global Dolutegravir/Rilpivirine Combination Drug Market Share Forecast by Type (2019-2024)
Table Global Dolutegravir/Rilpivirine Combination Drug Sales Forecast by Application (2019-2024)
Table Global Dolutegravir/Rilpivirine Combination Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

Global Dolutegravir and Its Combination Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1834 2019年8月 116Pages
本調査レポートは、ドルテグラビル及び併用薬の世界市場について調べ、まとめました。種類別セグメントは、ドルテグラビル、アバカビル/ドルテグラビル/ラミブジン、ドルテグラビル/リルピビリン等、用途別セグメントは、医療産業、IT産業、サービス産業等に区分しました。ドルテグラビル及び併用薬の世界市場概観、企...

テノホビル/エムトリシタビン配合剤の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Tenofovir/Emtricitabine Combination Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5703 2019年8月 116Pages
本調査レポートは、テノホビル/エムトリシタビン配合剤の世界市場について調べ、まとめました。種類別セグメントは、自己制作API、APIアウトソーシング等、用途別セグメントは、石油及びガス生産、送電、その他等に区分しました。テノホビル/エムトリシタビン配合剤の世界市場概観、企業動向、企業別テノホビル/エ...

エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1950 2019年8月 122Pages
本調査レポートは、エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場について調べ、まとめました。種類別セグメントは、10テーブル、30テーブル等、用途別セグメントは、冷却水システム/工業用水処理、工業用洗剤、金属表面処理、H 2 O 2溶液中での安定剤、繊維助剤中での封鎖剤等に区分しました...

エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C2071 2019年8月 102Pages
本調査レポートは、エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場について調べ、まとめました。種類別セグメントは、自己制作API、APIアウトソーシング等、用途別セグメントは、医療産業、IT産業、サービス産業等に区分しました。エムトリシタビン/リルピビリン/テノホビルアラフェンア...

リルピビリンの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Rilpivirine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C4965 2019年7月 121Pages
本調査レポートは、リルピビリンの世界市場について調べ、まとめました。種類別セグメントは、ロータータイプ乾燥剤除湿機等、用途別セグメントは、等に区分しました。リルピビリンの世界市場概観、企業動向、企業別リルピビリンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロ...

エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C2063 2019年8月 118Pages
本調査レポートは、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場について調べ、まとめました。種類別セグメントは、1本/箱、3本/箱等、用途別セグメントは、メディア、コミュニケーション、医療等に区分しました。エルビテグラビル/コビシスタット/エムトリシタ...

テノホビルアラフェンアミド及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Tenofovir Alafenamide and Its Combination Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5700 2019年7月 121Pages
本調査レポートは、テノホビルアラフェンアミド及び併用薬の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、病院、診療所、その他等に区分しました。テノホビルアラフェンアミド及び併用薬の世界市場概観、企業動向、企業別テノホビルアラフェンアミド及び併用薬シェア、市場規模推移、...

ドルテグラビルの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Dolutegravir Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1833 2019年8月 118Pages
本調査レポートは、ドルテグラビルの世界市場について調べ、まとめました。種類別セグメントは、10mg錠、50mg錠等、用途別セグメントは、潜在的曝露後のHIV感染予防、その他等に区分しました。ドルテグラビルの世界市場概観、企業動向、企業別ドルテグラビルシェア、市場規模推移、市場規模予測（2019年-2...

ドルテグラビルナトリウムの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Dolutegravir Sodium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1835 2019年8月 115Pages
本調査レポートは、ドルテグラビルナトリウムの世界市場について調べ、まとめました。種類別セグメントは、ボトル包装、フィルムコーティング包装等、用途別セグメントは、エイズ成人患者、12歳以上のエイズ小児等に区分しました。ドルテグラビルナトリウムの世界市場概観、企業動向、企業別ドルテグラビルナトリウムシェ...

エルビテグラビル配合薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Elvitegravir Combination Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C2062 2019年8月 122Pages
本調査レポートは、エルビテグラビル配合薬の世界市場について調べ、まとめました。種類別セグメントは、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビル併用薬等、用途別セグメントは、通信産業、医療産業等に区...

ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
テノホビル/エムトリシタビン配合剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th…
エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Emtricitabine/Rilpivirine/Tenofovir Alafenamide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuse…
リルピビリンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Rilpivirine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Rilpivirine in global marke…
エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Efavirenz/Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report foc…